TY  - JOUR
AU  - Bartoletti, Michele
AU  - Azap, Ozlem
AU  - Barac, Aleksandra
AU  - Bussini, Linda
AU  - Ergonul, Onder
AU  - Krause, Robert
AU  - Martin-Quiros, Alejandro
AU  - Paño-Pardo, José Ramón
AU  - Power, Nicholas
AU  - Sibani, Marcella
AU  - Szabo, Balint Gergely
AU  - Tsiodras, Sotirios
AU  - Zollner-Schwetz, Ines
AU  - Rodríguez-Baño, Jesús
PY  - 2022
DO  - 10.1016/j.cmi.2022.08.013
UR  - http://hdl.handle.net/10668/22136
T2  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
AB  - Despite the large availability of vaccines, coronavirus disease 2019 (COVID-19), induced by severe acute respiratory syndrome coronavirus 2, continues to be a major threat for health-care providers and fragile people. A number of options are now...
LA  - en
KW  - COVID-19
KW  - Cilgavimab
KW  - ESCMID
KW  - Molnupiravir
KW  - Nirmatrelvir/ritonavir
KW  - Outpatients
KW  - Remdesivir
KW  - Sotrovimab
KW  - Tixagevimab
KW  - Humans
KW  - Antibodies, Monoclonal
KW  - Communicable Diseases
KW  - Antineoplastic Agents, Immunological
KW  - COVID-19 Drug Treatment
TI  - European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease.
TY  - research article
VL  - 28
ER  -